From our December 2019 Newsletter

NEWS AND ANNOUNCEMENTS

1. WHO announces changes to the treatment of drug-resistant tuberculosis
Significant improvements in treatment outcomes and quality of life for patients with drug-resistant tuberculosis (TB) are expected, following key updates to treatment approaches, announced by WHO.
2. TB Alliance responds to questions raised by activists in relation to pretomanid
MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.
3. Save the Date! RESIST-TB will be hosting a webinar in the new year!
Mark your calendar for Monday, January 27th from 08:00 to 9:00 EST (13:00-14:00 CET) for a presentation from Molly Franke, ScD, Associate Professor of Global Health and Social Medicine, Harvard Medical School, and Carly Rodriguez, MPH, PhD Candidate in Epidemiology, Boston University School of Public Health on Approaches for improving inference from observational multi-drug resistant tuberculosis (MDR-TB) treatment cohorts.